Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |